Report post
Does Gamida Cell Ltd (GMDA) beat earnings expectations?
The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations. Gamida Cell Ltd. (NASDAQ:GMDA) Q3 2023 Earnings Call Transcript November 14, 2023 Gamida Cell Ltd. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.15.Does GMDA have company insights?
GMDA does not have Company Insights People Also Watch XERSXeris Biopharma Holdings, Inc. 2.0200 +2.02% KZRKezar Life Sciences, Inc. 0.7680 -0.56% AUTLAutolus Therapeutics plc 4.0700 +3.56% GRTXGalera Therapeutics, Inc. 0.1953 +2.79% AVROAVROBIO, Inc. 1.3900 +1.46% EVLOEvelo Biosciences, Inc. 0.0490 +19.51% RDHLRedHill Biopharma Ltd. 0.4827 +4.93%What is GMDA performance?
Performance Overview: GMDA Trailing total returns as of 5/16/2024, which may include dividends or other distributions. Benchmark is S&P 500 YTD Return GMDA 92.08% S&P 500 11.05% 1-Year Return GMDA 98.40% S&P 500 28.06% 3-Year Return GMDA 99.50% S&P 500 26.91% 5-Year Return GMDA 99.54% S&P 500 85.80% Compare To: GMDA Compare